Tributyrin (ProButyrate)

Tributyrin (ProButyrate) is a stable butyric acid derivative that releases butyrate in the colon to nourish colonocytes and support gut barrier function. It works by delivering butyrate directly to colonic epithelial cells, where it serves as the primary energy source and regulates inflammatory responses.

Origin & History

Tributyrin is a triglyceride composed of three butyrate molecules attached to a glycerol backbone. It is naturally found in butter and is produced industrially for supplementation through esterification processes. ProButyrate is a specialized form designed for enhanced delivery of butyrate to the gut.

Historical & Cultural Context

Tributyrin is a triglyceride form of butyrate and has been explored for its potential to improve gut health in modern nutritional science.

Health Benefits

- Supports gut health by releasing butyrate, which nourishes colon cells and enhances digestion. - Reduces inflammation by modulating gut microbiota, decreasing systemic inflammatory markers. - Enhances metabolic health by improving insulin sensitivity, reducing the risk of metabolic syndrome. - Boosts immune function by strengthening the intestinal barrier, preventing pathogen invasion. - Supports mental health by increasing butyrate levels, linked to improved mood and cognitive function. - Aids in weight management by promoting satiety hormones, helping to control appetite. - Improves cardiovascular health by lowering cholesterol levels and supporting heart function.

How It Works

Tributyrin releases butyrate through enzymatic hydrolysis by pancreatic and intestinal lipases in the small intestine and colon. Butyrate activates G-protein coupled receptors GPR41 and GPR43, inhibits histone deacetylases (HDACs), and serves as the primary fuel source for colonocytes. This process strengthens tight junction proteins like claudin-1 and occludin while promoting regulatory T-cell differentiation through epigenetic modifications.

Scientific Research

Tributyrin has been the subject of research for its potential to deliver butyrate more effectively to the colon, with studies indicating benefits for gut health and inflammation reduction.

Clinical Summary

Human studies on tributyrin supplementation are limited, with most research conducted in animal models and in vitro studies. A small pilot study (n=24) showed tributyrin improved gut barrier function markers after 4 weeks of supplementation. Animal studies demonstrate significant reductions in colonic inflammation and improved insulin sensitivity with doses equivalent to 500-1000mg daily in humans. More robust clinical trials are needed to establish definitive therapeutic benefits and optimal dosing protocols.

Nutritional Profile

Tributyrin (ProButyrate) is a triglyceride ester composed of three butyrate molecules bound to a glycerol backbone. Macronutrient profile: primarily fat-based (~9 kcal/g), with no significant protein or carbohydrate content. Bioactive compounds: Butyrate (~68-70% by molecular weight), released as free butyric acid (C4:0) upon enzymatic hydrolysis by pancreatic lipases and intestinal esterases; glycerol backbone (~10-12% by weight) released as a metabolic substrate. Butyrate concentration per typical serving (300-600 mg tributyrin): approximately 200-420 mg bioavailable butyrate. Key bioactive roles: short-chain fatty acid (SCFA) acting as primary energy substrate for colonocytes (~60-70% of colonocyte energy demand); histone deacetylase (HDAC) inhibitor at micromolar concentrations (IC50 ~2-5 mM intracellularly); G-protein coupled receptor (GPR41, GPR43, GPR109A) agonist. Bioavailability notes: Tributyrin demonstrates significantly superior bioavailability compared to sodium butyrate (~4-6x greater colonic delivery); protected from upper GI degradation and odor due to esterified form; hydrolysis occurs progressively through small intestine into colon, enabling sustained-release butyrate delivery; oral bioavailability estimated at 70-85% of administered dose reaching target colonic tissue. Micronutrients: negligible mineral or vitamin content inherent to the compound itself.

Preparation & Dosage

Dosage typically ranges from 300 mg to 1 gram per day. Consult a healthcare provider before use.

Synergy & Pairings

Prebiotics, Probiotics, Polyphenols

Safety & Interactions

Tributyrin is generally well-tolerated with mild gastrointestinal effects like bloating or loose stools reported at higher doses. No significant drug interactions have been documented, though it may enhance the effects of anti-diabetic medications by improving insulin sensitivity. Safety during pregnancy and lactation has not been established. Individuals with severe inflammatory bowel disease should consult healthcare providers before use due to potential alterations in gut microbiota composition.